Blood Group Typing Market Size, Key Players and Forecast to 2024

1. Biotechnology Blood Group Typing Market Size, Segment Analysis, Growth Drivers and Forecast Report 2024 © P&S Intelligence. All rights reserved 1

2. Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typing market has witnessed significant growth due to the advancement in technology which has improved detection methods. The global blood group typing market is categorized on the basis of the product and service offerings; techniques used; type of tests; and its end users. Based on product and services, the global market is segmented into consumables, instruments and services. Consumable, which includes blood bank saline, anti-human globulin reagents, antisera reagents and red blood cells reagents, held largest share in the global blood typing market in 2016. It has major contribution towards the growth of the global group typing market as compared to other segments. The major factor driving this growth are increasing rate of blood donation and major surgical procedures like organ transplantation. Download sample copy https://www.psmarketresearch.com/market-analysis/blood-group-typing- market/report-sample Massively parallel sequencing, polymerase chain reaction (PCR) based and microarray techniques, assay-based techniques and other techniques are used for blood group typing. Among different techniques, the global PCR-based and microarray blood group typing market is expected to witness the fastest growth during the forecast period (2017 – 2023). Increase in R&D activities on understanding the molecular basis of blood and antibody-antigen interactions, and rise in chronic diseases has resulted in increase in the use of PCR-based and microarray techniques. Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of of this report at: © P&S Intelligence. All rights reserved 2

3. blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks. Growth Drivers The global blood group typing market is expected to grow significantly during the forecast period. The major driving force behind this growth are the increase in the use of blood group typing in forensic science; need for grouping of the blood during pregnancy and prenatal testing; growth in the number of road accidents and trauma cases that requires blood transfusion; increase in the demand of blood and blood products; and rise in blood donation. Blood group typing is very crucial for the detection of hemolytic disease of the newborn (HDN) in pregnant women which eventually stimulates the usage of blood group typing, hence causing the growth of the global market. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send- enquiry?enquiry-url=blood-group-typing-market Opportunities and Trends The development of novel molecular diagnostic tools which helps in reliable and rapid identification of blood groups in large samples is expected to provide abundant opportunities to the market players. The rise in the number of blood donations is the key trend witnessed in the global blood group typing market. Also, the technology advancements like quantum dots (QDs) and magnetic beads in assays that improve identification and enhance clinical safety of blood transfusion have also been witnessed globally. Competitive Landscape They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc. © P&S Intelligence. All rights reserved 3

4. In October 2016, Bio-Rad Laboratories, Inc., a manufacturer of life sciences and clinical diagnostic products, received the U.S. Food and Drug Administration (FDA) approval for its IH-1000 blood instrument. In May 2014, Immucor’s PreciseType HEA Test received FDA approval to be used for screening blood donors for sickle cell trait (SCT). The PreciseType HEA test is the FDA-approved molecular assay designed to provide blood banks and clinicians with the detailed genetic matching information that they need to reduce the risk of alloimmunization and serious haemolytic reactions, which is especially problematic for patients receiving frequent blood transfusions. Read more: https://www.psmarketresearch.com/market-analysis/blood- group-typing-market © P&S Intelligence. All rights reserved 4

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved 5